United States · FDA National Drug Code directory
Oxcarbazepine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69452-125_44eb29ac-e607-a84a-e063-6394a90a9e72
- Product NDC
- 69452-125
- Form
- SUSPENSION
- Composition / generic term
- Oxcarbazepine
- Labeler
- Bionpharma Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230214
- Source listing expiry
- 20261231
Source-listed ingredients
- OXCARBAZEPINE — 300 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, GLASS in 1 CARTON (69452-125-50) / 250 mL in 1 BOTTLE, GLASS · 69452-125-50
- 1 BOTTLE, PLASTIC in 1 CARTON (69452-125-51) / 250 mL in 1 BOTTLE, PLASTIC · 69452-125-51
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →